Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma-Reference-Cited by-同舟云学术

Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma

Published:2021-09 Issue:9 Volume:9 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Omori Ginji¹^ORCID,Osuga Takahiro¹,Miyanishi Koji¹^ORCID,Hamaguchi Kota¹,Tanaka Shingo¹²,Ohnuma Hiroyuki¹,Murase Kazuyuki¹,Takada Kohichi¹,Nagayama Minoru³,Kimura Yasutoshi³,Takemasa Ichiro³,Kikuchi Yasuhiro⁴,Torigoe Toshihiko⁴,Kato Junji¹^ORCID

Affiliation:

1. Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan

2. Department of Infection Control and Laboratory Medicine Sapporo Medical University School of Medicine Sapporo Japan

3. Department of Surgery, Surgical Oncology and Science Sapporo Medical University School of Medicine Sapporo Japan

4. Department of Pathology Sapporo Medical University School of Medicine Sapporo Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.4764

Reference31 articles.

1. LYMPHOEPITHELIOMA OF THE NASOPHARYNX

2. Lymphoepithelioma-like Hepatocellular Carcinoma

3. The Role of Epstein-Barr Virus in Lymphoepithelioma-like Carcinomas

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent expression of PD-L1 in lymphocyte-rich hepatocellular carcinoma: A report of 4 cases;Annals of Diagnostic Pathology;2023-10

2. Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma;Cancers;2022-09-23